Efficacy-Safety-Immunogenicity Study of CBT124&EU-sourced Avastin® in Stage 4 NSCLC

Clinical trial NCT02879097 · UNKNOWN

Trial details

NCT number: NCT02879097
Sponsor: Cipla BioTec Pvt. Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Small Cell Lung Carcinoma

Start date: 2016-12-01
Primary completion: 2017-12-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.